Benign prostatic hyperplasia (BPH) and prostate cancer are the most common hyperplastic and neoplastic diseases in U.S. males, and the incidence of both is increasing yearly. To understand the cellular and molecular basis of these diseases, we have developed mouse models for growing both human and rodent prostate tumors in vivo. These models were developed based on an observation that nontumorigenic mesenchymal cells can accelerate human epithelial tumor growth in athymic mice. Using a human prostate epithelial cell line, LNCaP, as a model, we have observed that prostate and bone fibroblasts are most effective in accelerating LNCaP tumor growth in the male hosts. The fibroblast specificity in tumor induction mimicked the natural history of human prostate cancer, which progresses from its primary with a propensity to metastasize to the bone. We have developed a novel method of delivering concentrated growth factor (GF) fractions obtained from fibroblast-conditioned medium (CM) in vivo on a Gelform matrix and have observed the occurrence of local angiogenesis, LNCaP tumor growth, and prostate specific antigen secretion. In the proposed study, we will pursue the following objectives: 1) To characterize the factor(s) present in prostate and bone mesenchymal cells that is responsible for inducing LNCaP tumor growth in vivo. We will define the role of sex steroids and examine the GF and extracellular matrix (ECM) pathways involved in LNCaP tumor growth, using suramin and GF/ECM antibodies as tools. 2) To examine the mechanism for epithelial cell-mediated acceleration of mesenchymal cell proliferation in vivo. We will define and characterize the effects of sex steroid, GF, and CM on mesenchymal cell growth in vivo and in vitro. 3) To establish both BPH and prostate cancer models in athymic mice, using either established cell lines (strains) or primary lines obtained from surgical specimens. The sensitivity of these prostate tumor models toward steroid agonists and antagonists will be examined. 4) To develop a three- dimensional cell culture system in which to examine the cellular basis of mesenchymal-epithelial interaction. We hope that this new cell culture system will provide a structural frame work in which the epithelial cells can express tissue-specific proteins, polarized secretory functions, and morphogenesis. The overall goal of this proposal is to further our understanding at the biochemical and cellular levels of the mesenchymal- epithelial interaction in human BPH and prostate cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA056307-01
Application #
3200713
Study Section
Metabolic Pathology Study Section (MEP)
Project Start
1991-08-01
Project End
1994-07-31
Budget Start
1991-08-01
Budget End
1992-07-31
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
Other Domestic Higher Education
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Sang, Q A; Schwartz, M A; Li, H et al. (1999) Targeting matrix metalloproteinases in human prostate cancer. Ann N Y Acad Sci 878:538-40
Thalmann, G N; Sikes, R A; Chang, S M et al. (1996) Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer. J Natl Cancer Inst 88:794-801
Zhau, H Y; Zhou, J; Symmans, W F et al. (1996) Transfected neu oncogene induces human prostate cancer metastasis. Prostate 28:73-83
Zhau, H Y; Chang, S M; Chen, B Q et al. (1996) Androgen-repressed phenotype in human prostate cancer. Proc Natl Acad Sci U S A 93:15152-7
Chung, L W (1995) The role of stromal-epithelial interaction in normal and malignant growth. Cancer Surv 23:33-42
Hall, M C; Navone, N M; Troncoso, P et al. (1995) Frequency and characterization of p53 mutations in clinically localized prostate cancer. Urology 45:470-5
Pisters, L L; Troncoso, P; Zhau, H E et al. (1995) c-met proto-oncogene expression in benign and malignant human prostate tissues. J Urol 154:293-8
Hall, M C; Troncoso, P; Pollack, A et al. (1994) Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy. Urology 44:869-75
Wu, H C; Hsieh, J T; Gleave, M E et al. (1994) Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. Int J Cancer 57:406-12
Thalmann, G N; Anezinis, P E; Chang, S M et al. (1994) Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 54:2577-81

Showing the most recent 10 out of 21 publications